Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2023-04-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（ 黄文表）
Regulatory Filings Classification · 95% confidence The document is a public statement by an independent director candidate of a company, declaring compliance with various legal and regulatory requirements for serving as an independent director. It contains no financial data, no report or financial results, and no announcement of voting results or meeting materials. It is a regulatory compliance declaration related to board/management qualifications but does not announce a change in board or management itself. It is not a certification letter or a report publication announcement. The content fits best under Regulatory Filings (RNS) as a compliance disclosure that does not fit other categories.
2023-04-25 Chinese
监事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the supervisory board of a company regarding the approval of the company's 2023 first quarter report and the proposal for the election of new supervisory board members. It includes details about the meeting, voting results, and candidate biographies. The document does not contain the actual financial statements or detailed financial data of the quarterly report but rather the supervisory board's resolution and approval of that report. The document length is short (1741 characters) and serves as an official announcement of the meeting's resolutions and supervisory board changes. This fits best under the category of Board/Management Information (MANG) because it announces changes in the supervisory board and related governance matters. It is not the quarterly report itself (IR), nor a simple announcement of report publication (RPA).
2023-04-25 Chinese
独立董事候选人声明（ 雷振华）
Board/Management Information Classification · 95% confidence The document is a public statement by an independent director candidate of a company, declaring compliance with various legal and regulatory requirements for serving as an independent director. It includes detailed attestations about qualifications, independence, and absence of conflicts of interest. There is no financial data, no discussion of company performance, no voting results, no meeting materials, and no mention of report publication. The content is focused on board/management information, specifically about the appointment and qualifications of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive, not a mere announcement or certification, so it is not Regulatory Filings (RNS).
2023-04-25 Chinese
启迪药业2022年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled '2022年度股东大会' which translates to '2022 Annual General Meeting'. It contains detailed meeting materials including the agenda, reports to be reviewed, voting procedures, and various proposals to be discussed and voted on during the meeting. The content includes the full text and summary of the 2022 Annual Report, Board and Supervisory reports, financial statements, profit distribution plans, and other governance matters. The document is clearly the presentation and materials shared during the Annual General Meeting rather than the annual report itself or an announcement of the report. The length and detail confirm it is not a brief announcement or a certification. Therefore, the document fits the category of AGM Information (AGM-R).
2023-04-25 Chinese
独立董事提名人声明（二 ）
Board/Management Information Classification · 100% confidence The document is a public statement regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and contains substantive content about management changes rather than a brief announcement or regulatory filing.
2023-04-25 Chinese
独立董事关于第九届董事会第八次会议的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on the company's board election and senior management appointment, referencing compliance with corporate governance rules and company bylaws. It discusses the nomination and qualifications of board candidates and the appointment of a vice president. There is no financial data, earnings information, or report publication mentioned. The content is focused on board and management changes, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or regulatory filing. Therefore, the classification is MANG with high confidence.
2023-04-25 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.